Zomedica Corp (NYSE American:ZOM)
Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc.2019. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates.
© 2021 Cable News Network. A Warner Media Company. All Rights Reserved.
CNN Sans™ & © 2016 Cable News Network.
Zomedica Pharmaceuticals Corp Stock Forecast NYSE:ZOM
Zomedica Pharmaceuticals Corp stock price ended on $0.51 on Wednesday after gaining 2.9%
(Updated on Oct 13, 2021)
Hold candidate since 2021-10-12Gain 2.90% PDF
The Zomedica Pharmaceuticals Corp stock price gained 2.90% on the last trading day (Wednesday, 13th Oct 2021), rising from $0.50 to $0.51. During the day the stock fluctuated 3.96% from a day low at $0.50 to a day high of $0.52. The price has fallen in 6 of the last 10 days, but is still up by 1.38% over the past 2 weeks. Volume fell on the last day by -2 million shares and in total, 11 million shares were bought and sold for approximately $5.85 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -14.35% during the next 3 months and, with a 90% probability hold a price between $0.34 and $0.54 at the end of this 3-month period.
Signals & Forecast
A buy signal was issued from a pivot bottom point on Monday, September 20, 2021, and so far it has risen 4.59%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Zomedica Pharmaceuticals Corp stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $0.55. On a fall, the stock will find some support from the short-term average at $0.51. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.
Support, Risk & Stop-loss
Zomedica Pharmaceuticals Corp finds support from accumulated volume at $0.51 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0199 between high and low, or 3.96%. For the last week, the stock has had a daily average volatility of 2.98%.
Our recommended stop-loss: $0.49 (-5.28%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 17 days ago.)
Is Zomedica Pharmaceuticals Corp stock A Buy?
Zomedica Pharmaceuticals Corp holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: -0.446
Predicted Opening Price for Zomedica Pharmaceuticals Corp of Thursday, October 14, 2021
The predicted opening price is based on yesterday's movements between high, low, and the closing price.
|Fair opening price October 14, 2021||Current price|
Remember To Visit Our YouTube Channel
HC Wainwright is very positive about ZOM and gave it a "Buy" rating on Nov 16, 2020. The price target was changed from $0.50 to $0.30.
Overall Risk: Very HighHighMediumLowVery Low
Daily Average Volatility
- Grande stacker box
- Minecraft mountain update
- Antique plant stands wood
- Zeta psi letters
- Microlight trikes for sale
Zomedica Pharmaceuticals Stock Target Price and Analyst Consensus
Quick AdviceNews TimelineCalendarExposure
|ZOM||- USA Stock|
USD 0.51 0.01 2.00%
Analysts of Zomedica Pharmaceuticals render investment recommendations by dissecting financials, analyzing earning calls, and talking to Zomedica Pharmaceuticals vendors, executives, and customers to validate their buy-or-sell advice. Unfortunately, the analyst consensus on Zomedica Pharmaceuticals is currently unavailable. Please use our comprehensive buy-or-sell advice module to check the latest Macroaxis investment opinion on Zomedica Pharmaceuticals
About Zomedica Pharmaceuticals Target Price Projections
Zomedica Pharmaceuticals's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Zomedica Pharmaceuticals and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Zomedica depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Zomedica Pharmaceuticals Corp
Additional Zomedica Pharmaceuticals Value Projection ModulesMost investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Zomedica Pharmaceuticals is a key component of Zomedica Pharmaceuticals valuation and have some predictive power on the future returns of a Zomedica Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Zomedica Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Zomedica Pharmaceuticals in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Zomedica Pharmaceuticals. Your research has to be compared to or analyzed against Zomedica Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Zomedica Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Zomedica Pharmaceuticals.
Currently Trending ThemesIf you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Invested over 100 shares
Check out Macroaxis Advice on Zomedica Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Zomedica Pharmaceuticals information on this page should be used as a complementary analysis to other Zomedica Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Zomedica Stock analysis
When running Zomedica Pharmaceuticals price analysis, check to measure Zomedica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zomedica Pharmaceuticals is operating at the current time. Most of Zomedica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Zomedica Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Zomedica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Zomedica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
|Price TransformationUse Price Transformation models to analyze depth of different equity instruments across global markets||Go|
|Piotroski F ScoreGet Piotroski F Score based on binary analysis strategy of nine different fundamentals||Go|
|Equity SearchSearch for activelly traded equities including funds and ETFs from over 30 global markets||Go|
|Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity||Go|
|Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency||Go|
|Fund ScreenerFind activelly-traded funds from around the world traded on over 30 global exchanges||Go|
|Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios||Go|
|Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets||Go|
|My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like||Go|
|Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum||Go|
The data published in Zomedica Pharmaceuticals' official financial statements usually reflect Zomedica Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Zomedica Pharmaceuticals. For example, before you start analyzing numbers published by Zomedica accountants, it's critical to develop an understanding of what Zomedica Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Zomedica Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zomedica Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Zomedica Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Zomedica Pharmaceuticals Corp. Please utilize our Beneish M Score to check the likelihood of Zomedica Pharmaceuticals' management to manipulate its earnings.
Zomedica (ZOM) stock Forecast for 2021 – 2025
Zomedica Stock Forecast 10-16-2021.Forecast target price for 10-16-2021: $dynamics for Zomedica shares will prevail with possible volatility of
Zomedica Stock Forecast 10-17-2021.Forecast target price for 10-17-2021: $dynamics for Zomedica shares will prevail with possible volatility of
Zomedica Stock Forecast 10-18-2021.Forecast target price for 10-18-2021: $dynamics for Zomedica shares will prevail with possible volatility of
Zomedica Stock Forecast 10-19-2021.Forecast target price for 10-19-2021: $dynamics for Zomedica shares will prevail with possible volatility of
Zomedica Stock Forecast 10-20-2021.Forecast target price for 10-20-2021: $dynamics for Zomedica shares will prevail with possible volatility of
Zomedica Stock Forecast 10-21-2021.Forecast target price for 10-21-2021: $dynamics for Zomedica shares will prevail with possible volatility of
Target zomedica price
Kostya puffed, with might and main driving my penis into the vagina up to the balls, but already. Slowed down and tore me measuredly with a broach as I loved. I do not like when they have me like a jackhammer, no, this is not mine, I like when they plant me not too quickly.ZOMEDICA ZOM STOCK SET TO BLOW UP ? IS IT TIME TO LOAD THE BOAT? + ANALYST PRICE TARGETS ! 🚀💰
Do you want to become human. his voice was completely calm and friendly. I said nothing. - I can not hear.
You will also be interested:
- Sweetwater demo models
- Is aptoide safe
- Fedex locations austin texas
- Paper moon lyrics
- Husqvarna backpack blower
- Silver hallway table
- Going away invitation
- Brosnan security address
- Twin soul separation pain
Thick, sticky, with an animal smell, liquid. The eruption seemed to have no end. I looked at the sleeping black man and barely remembered his name, sometimes I asked who he was, sank down on. His penis, shuddered all over, shrank inside, stopped breathing and only felt inside.
I cant stand it, I cant take it anymore, I cant stand it any longer and restrain myself.